Why Tracer?

Fastest In-Human

Accelerating decisions by imaging drug binding

Learn how
Latest resources | See all resources
More about us

At TRACER, accurate data is in our DNA. We front run with a passion for precision to lead you to faster and better decision-making. Offering fast customised quality through our unique working methodology.

Go van Dam, CEO

Radiopharmaceuticals are on the rise as drug developers realize enormous potential

Prof. G.M. van Dam, MD, PhD
Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Floris Jan Voskuil, Steven Jakob de Jongh, Wouter Tjerk Rudolph Hooghiemstra, Matthijs David Linssen, Pieter Jan Steinkamp, Sebastiaan Antonius Hendrik Johannes de Visscher, Kees-Pieter Schepman, Sjoerd Geert Elias, Gert-Jan Meersma, Pascal Klaas Christiaan Jonker, Jan Johannes Doff, Annelies Jorritsma-Smit, Wouter Bastiaan Nagengast, Bert van der Vegt, Dominic James Robinson, Gooitzen Michell van Dam, Max Johannes Hendrikus Witjes
Theranostics 2020; 10(9): 3994-4005. doi:10.7150/thno.43227